Published on January 5, 2010 at 1:24 AM
According to an article in the January 2010 edition of Drugs In Dermatology (abstract available at
http://jddonline.com ), the use of botulinum type A toxins such as Botox and
Dysport may offer a cost efficient alternative to the use of
selective serotonin reuptake inhibitors. Kenneth Beer MD, who authored the article, says that he began to consider the possibility that injections of Botox and Dysport might be cost effective after reading an article by Finzi et al published in the Journal of Dermatologic Surgery. Dr. Beer then began to notice that many of his patients began to feel better after they started to look better.
According to Dr. Beer, "So many people take medications for depression that I wondered whether injections with type A botulinum toxins could offer them a better alternative. I collected some very preliminary data comparing the costs of each of the therapies and was surprised at the results."
Dr. Beer cautions that this report needs to be validated with a larger study and he hopes that such a trial will be initiated under the auspices of the National Institute for Mental Health.
SOURCE Kenneth Beer MD